High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R00AI138860
National Institute of Allergy and Infectious Diseases
Grant: R01AI098446
National Institute of Allergy and Infectious Diseases
Grant: U19AI149646
NIAID NIH HHS
Grant: P30 AI073961
NIH HHS
Grant: P51 OD011132
National Institutes of Health
Grant: 1R01AI098446-01A1
Immunoglobulins Delivered by AAV Vector for the Prevention of SIV Infection
National Institutes of Health
Grant: 4R00AI138860-03
AAV-Delivered Broadly Neutralizing Antibodies for HIV Suppression
National Institutes of Health
Grant: 6U19AI149646-03
An AAV-mediated functional cure and its impact on the reservoir
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals